Background: Although hepatocellular carcinoma was historically considered an important scourge in Middle Africa, there is no publication describing this disease in Chad. Methods: We conducted a retrospective analysis of 219 patients with hepatocellular carcinoma (HCC) attending care at the University Reference Hospital of Ndjamena between 2007 and 2016. Results: This series of HCC was characterized by a male predominance (M:F = 2.4) with a mean tumor onset at the end of the fifth decade of life (49.9 ± 14.7 years). Tumors appear on a cirrhotic liver in 70% of cases and were already multifocal at diagnosis in two thirds of the patients. Alpha-fetoprotein was above the physiological threshold (10 ng/mL) in 73.4% of cases measured and above the so-called diagnostic level (400 ng/mL) in 53.4% of patients. The principal risk factor was chronic infection with hepatitis B virus, detected in 52.6% of cases. Patients seropositive for hepatitis C virus were infrequent (8.6%) and heavy alcohol intake was even less prevalent (5.9%). Remarkably, a very large subset of patients did not present any infectious or lifestyle risk factor (43.4%). Mean AFP values or fibrosis assessment scores are usually lower in these patients than in HBV-infected ones. Conclusions: The etiological spectrum of HCC is far from being fully established in Chad. Further epidemiological research is warranted to identify risk factors involved in a large proportion of cases. Exposure to aflatoxin B1 and dysmetabolic conditions affecting the liver have to be investigated as priority.
Kew, M. (2013) Epidemiology of Hepatocellular Carcinoma in Sub-Saharan Africa. Annals of Hepatology, 12, 173-182. https://doi.org/10.1016/S1665-2681(19)31354-7
Yang, J., Ea, M., AbdelAziz, A., Shousha, H., Hashem, M., Nabeel, M., Abdbdelmaksoud, A., et al. (2017) Characteristics, Management, and Outcomes of Patients with Hepatocellular Carcinoma in Africa: A Multicountry Observational Study from the Africa Liver Cancer Consortium. The Lancet Gastroenterology and Hepatology, 2, 103-111.
Lemoine, M., Eholié, S. and Lacombe, K. (2015) Reducing the Neglected Burden of Viral Hepatitis in Africa: Strategies for a Global Approach. Journal of Hepatology, 62, 469-476. https://doi.org/10.1016/j.jhep.2014.10.008
Liu, Y. and Wu, F. (2010) Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment. Environmental Health Perspectives, 118, 818-824. https://doi.org/10.1289/ehp.0901388
Ferreira-Borges, C., Parry, C. and Babor, T. (2017) Harmful Use of Alcohol: A Shadow over Sub-Saharan Africa in Need of Workable Solutions. International Journal of Environmental Research and Public Health, 14, Article No. 346. https://doi.org/10.3390/ijerph14040346
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A. and Rehm, J. (2018) The Global Burden of Disease Attributable to Alcohol and Drug Use in 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Psychiatry, 5, 987-1012. https://doi.org/10.1016/S2215-0366(18)30337-7
Tognarelli, J., Ladep, N., Crossey, M., Okeke, E., Duguru, M., Banwat, E. and Taylor-Robinson, S. (2015) Reasons Why West Africa Continues to Be a Hotbed for Hepatocellular Carcinoma. Nigerian Medical Journal, 56, 231-235. https://doi.org/10.4103/0300-1652.165032
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R., Torre, L. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
Sartorius, K., Sartorius, B., Aldous, C., Govender, P. and Madiba, T. (2015) Global and Country Underestimation of Hepatocellular Carcinoma (HCC) in 2012 and Its Implications. Cancer Epidemiology, 39, 284-290. https://doi.org/10.1016/j.canep.2015.04.006
Bessimbaye, N., Moussa, A., Mbanga, D., Tidjani, A., Mahamat, S., Nahor Ngawara, M., Ngarnayal, G., Fissou, H., Sangare, L., Ndoutamia, G. and Barro, N. (2014) Séroprévalence de l’Ag HBs et de l’anticorps Anti VHC chez les personnes infectées par le VIH1 à N’Djamena, Tchad. Bulletin de la Societe de Pathologie Exotique, 107, 327-331. https://doi.org/10.1007/s13149-014-0386-1
Suesstrunk, J. and Djongali, F. (2017) Hepatitis B Virus Prevalence in Rural Areas in South-West Chad. Tropical Doctor, 47, 374-377. https://doi.org/10.1177/0049475517699718
Martinez, P., Røislien, J., Naidoo, N. and Thomas, C. (2011) Alcohol Abstinence and Drinking among African Women: Data from the World Health Surveys. BMC Public Health, 11, Article No. 160. https://doi.org/10.1186/1471-2458-11-160
Moussa, A. and Njouom, R. (2015) High Rate of Infection with Hepatitis C Virus Genotype 4 in Chad, Central Africa. Indian Journal of Microbiology, 33, 608-609. https://doi.org/10.4103/0255-0857.167343
Doutoum, A., Tidjani, A., Markhous, N., Nadlaou, B. and Doungous, D. (2019) Identification des moisissures et dosage des aflatoxines dans les ingrédients d’assaisonnement des brochettes de viande de bœuf consommées dans la ville de N’Djamena. Revue scientifique du Tchad. Série B, 35-40.
Joshi, S., Song, Y., Kim, T. and Cho, S. (2010) Socio-Economic Status and the Risk of Liver Cancer Mortality: A Prospective Study in Korean Men. Public Health, 122, 1144-1151. https://doi.org/10.1016/j.puhe.2008.04.003
Lange, C., Miki, D., Ochi, H., Nischalke, H., Bojunga, J., Bibert, S., Morikawa, K., Gouttenoire, J., et al. (2013) Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development. PLOS ONE, 8, e64053. https://doi.org/10.1371/journal.pone.0064053
Li, Y., Zhang, Z., Shi, J., Jin, L., Wang, L., Xu, D. and Wang, F. (2015) Risk Factors for Naturally-Occurring Early-Onset Hepatocellular Carcinoma in Patients with HBV-Associated Liver Cirrhosis in China. International Journal of Clinical and Experimental Medicine, 8, 1205-1212.
Wild, C., Miller, J. and Groopman, J. (2015) Effects of Aflatoxins on Aflatoxicosis and Liver Cancer, Mycotoxin Control in Low- and Middle-Income Countries. International Agency for Research on Cancer, Lyon, 13-16.
Didi-Kouko Coulibaly, J., Yeboua, M., Kouassi Mbengue, A., Allah Kouadio, E., Anzouan-Kacou Kissi, H., Binan, A., et al. (2017) Evolution of Hepatocellular Carcinoma Epidemiology in Côte d’Ivoire. Bulletin du Cancer, 104, 937-945. https://doi.org/10.1016/j.bulcan.2017.09.010
Yang, J., Afihene, M., Duduyemi, B., Micah, E., Kingham, T., Nyirenda, M., et al. (2015) Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association with Chronic Hepatitis B. American Journal of Gastroenterology, 110, 1629-1631. https://doi.org/10.1038/ajg.2015.289
Marchio, A., Amougou Atsama, M., Béré, A., Komas, N., Noah Noah, D., Atangana, P., et al. (2018) Droplet Digital PCR Detects High Rate of TP53 R249S Mutants in Cell-Free DNA of Middle African Patients with Hepatocellular Carcinoma. Clinical and Experimental Medicine, 18, 421-431. https://doi.org/10.1007/s10238-018-0502-9
Amougou Atsama, M., Noah Noah, D., Fewou Moundipa, P., Pineau, P. and Njouom, R. (2016) A Prominent Role of Hepatitis D Virus in Liver Cancers Documented in Central Africa. BMC Infectious Diseases, 16, Article No. 647. https://doi.org/10.1186/s12879-016-1992-2
Cunha, L., Carrilho, C., Bhatt, N., Loforte, M., Maueia, C., Fernandes, F., Guisseve, A., Mbofana, F., Mondlane, L., Ismail, M., Dimande, L., et al. (2019) Hepatocellular Carcinoma: Clinical-Pathological Features and HIV Infection in Mozambican Patients. Cancer Treatment and Research Communications, 19, Article ID: 100129. https://doi.org/10.1016/j.ctarc.2019.100129
Ladenheim, M., Kim, N., Nguyen, P., Le, A., Stefanick, M., Garcia, G. and Nguyen, M. (2016) Sex Differences in Disease Presentation, Treatment and Clinical Outcomes of Patients with Hepatocellular Carcinoma: A Single-Centre Cohort Study. BMJ Open Gastroenterology, 3, e000107. https://doi.org/10.1136/bmjgast-2016-000107
Fasani, P., Sangiovanni, A., De Fazio, C., Borzio, M., Bruno, S., Ronchi, G., Del Ninno, E. and Colombo, M. (1999) High Prevalence of Multinodular Hepatocellular Carcinoma in Patients with Cirrhosis Attributable to Multiple Risk Factors. Hepatology, 29, 1704-1707. https://doi.org/10.1002/hep.510290604
Li, Y., Li, H., Spitsbergen, J. and Gong, Z. (2017) Males Develop Faster and More Severe Hepatocellular Carcinoma than Females in krasV12 Transgenic Zebrafish. Scientific Reports, 7, Article No. 41280. https://doi.org/10.1038/srep41280
Ajayi, A., Ajayi, E. and Komolafe, O. (2009) Hepatocellular Carcinoma: Risk Factors, Pattern of Presentation and Outcome in a Tertiary Health Facility. International Journal of Medicine and Medical Sciences, 1, 84-87.
Gyedu, A., Shrauner, W. and Kingham, T. (2015) No Patients to Resect or Transplant: An Analysis of Patients with Hepatocellular Carcinoma Admitted to a Major African Referral Hospital. World Journal of Surgery, 39, 231-236. https://doi.org/10.1007/s00268-014-2762-1
Ada, A., Djibrillou, M. and Soly, I. (1998) Intérêt du dosage de l’alpha-foetoproteine plasmatique dans deux hépatopathies fréquetes en Afrique noire: Cirrhose et carcinome hépatocellulaire. Médecine d’Afrique Noire, 45, 464-466.
Bekondi, C., Mobima, T., Ouavènè, J., Koffi, B., Konamna, X., Béré, A. and Le Faou, A. (2010) Etiopathological Factors of Hepatocellular Carcinoma in Bangui, Central African Republic: Clinical, Biological Characteristics and Virological Aspects of Patients. Pathologie Biologie (Paris), 58, 152-155. https://doi.org/10.1016/j.patbio.2009.07.027
Ajayi, B., Nggada, H. and Moses, A. (2007) Hepatocellular Carcinoma among Patients Diagnosed with and without Hepatitis B Surface Antigenaemia in a Nigerian Tertiary Hospital. African Journal of Microbiology Research, 1, 121-124.
Omer, R., Van’t Veer, P., Kadaru, A., Kampman, E., el Khidir, I., Fedail, S. and Kok, F. (2001) The Role of Hepatitis B and Hepatitis C Viral Infections in the Incidence of Hepatocellular Carcinoma in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 487-491. https://doi.org/10.1016/S0035-9203(01)90013-6
Mustapha, S., Bolori, M., Ajayi, N., Nggada, H., Pindiga, U., Gashau, W. and Khalil, M. (2007) Hepatocellular Carcinoma in North-Eastern Nigeria: A Prospective Clinical Study of 100 Cases. The Internet Journal of Gastroenterology, 6, 1-5.
de Martel, C., Maucort-Boulch, D., Plummer, M. and Franceschi, S. (2015) World-Wide Relative Contribution of Hepatitis B and C Viruses in Hepatocellular Carcinoma. Hepatology, 62, 1190-1200. https://doi.org/10.1002/hep.27969
Sineque, A., Macuamule, C. and Dos Anjos, F. (2017) Aflatoxin b1 Contamination in Chicken Livers and Gizzards from Industrial and Small Abattoirs, Measured by ELISA Technique in Maputo, Mozambique. International Journal of Environmental Research and Public Health, 14, E951. https://doi.org/10.3390/ijerph14090951
Pavan Kedar Mukthinuthalapati, V.V., Sewram, V., Ndlovu, N., Kimani, S., Abdelaziz, A.O., Chiao, E.Y. and Abou-Alfa, G.K. (2021) Hepatocellular Crcinoma in Sub Saharian Africa. CO Global Oncology, 7, 756-766. https://doi.org/10.1200/GO.20.00425
Omer, R., Kuijsten, A., Kadaru, A., Kok, F., Idris, M., El Khidir, I. and van’t Veer, P. (2004) Population-Attributable Risk of Dietary Aflatoxins and Hepatitis B Virus Infection with Respect to Hepatocellular Carcinoma. Nutrition and Cancer, 48, 15-21. https://doi.org/10.1207/s15327914nc4801_3
N.R.F. Collaboration (2016) Trends in Adult Body-Mass Index in 200 Countries from 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies with 19.2 Million Participants. The Lancet, 387, 1387-1396. https://doi.org/10.1016/S0140-6736(16)30054-X
Swinburn, B., Kraak, V., Allender, S., Atkins, V., Baker, P., Bogard, J., et al. (2019) The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission Report. The Lancet, 393, 791-846. https://doi.org/10.1016/S0140-6736(18)32822-8
Ng, M., Fleming, T., Robinson, B., Thomson, B., Graetz, N., Margono, C., Mullany, E., et al. (2014) Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults during 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 766-781.